184 related articles for article (PubMed ID: 6112791)
1. Gastric cytoprotection by prostaglandins, ranitidine, and probanthine in rats. Role of endogenous prostaglandins.
Konturek SJ; Radecki T; Brzozowski T; Piastucki I; Dembińska-Kieć A; Zmuda A
Scand J Gastroenterol; 1981; 16(1):7-12. PubMed ID: 6112791
[TBL] [Abstract][Full Text] [Related]
2. Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine.
Guth PH; Aures D; Paulsen G
Gastroenterology; 1979 Jan; 76(1):88-93. PubMed ID: 361495
[TBL] [Abstract][Full Text] [Related]
3. Role of prostaglandins in the formation of aspirin-induced gastric ulcers.
Konturek SJ; Piastucki I; Brzozowski T; Radecki T; Dembińska-Kieć A; Zmuda A; Gryglewski R
Gastroenterology; 1981 Jan; 80(1):4-9. PubMed ID: 7450410
[TBL] [Abstract][Full Text] [Related]
4. Distinction between antiulcer effect and cytoprotection.
Robert A; Lancaster C; Davis JP; Field SO; Nezamis JE
Scand J Gastroenterol Suppl; 1984; 101():69-73. PubMed ID: 6599540
[TBL] [Abstract][Full Text] [Related]
5. Gastric cytoprotection by pirenzepine. Role of endogenous prostaglandins.
Konturek SJ; Brzozowski T; Radecki T; Piastucki I
Scand J Gastroenterol Suppl; 1982; 72():255-9. PubMed ID: 6957993
[TBL] [Abstract][Full Text] [Related]
6. Aspirin-induced gastric ulcers in cats. Prevention by prostacyclin.
Konturek SJ; Radecki T; Brzozowski T; Piastucki I; Zmuda A; Dembińska-Kieć A
Dig Dis Sci; 1981 Nov; 26(11):1003-12. PubMed ID: 6117433
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man.
Konturek SJ; Kwiecień N; Obtułowicz W; Polański M; Kopp B; Oleksy J
Gut; 1983 Feb; 24(2):89-93. PubMed ID: 6133815
[TBL] [Abstract][Full Text] [Related]
8. Gastric cytoprotection by antacids and papaverine in rats.
Hagel J; Renner H; Hirsch M; Weig G; Kaduk B; Ruppin H; Domschke W
Hepatogastroenterology; 1982 Dec; 29(6):271-4. PubMed ID: 6295902
[TBL] [Abstract][Full Text] [Related]
9. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice.
Takeuchi K; Araki H; Umeda M; Komoike Y; Suzuki K
J Pharmacol Exp Ther; 2001 Jun; 297(3):1160-5. PubMed ID: 11356942
[TBL] [Abstract][Full Text] [Related]
10. Effect of PGF2 alpha administered in cytoprotective and antisecretory doses on the ethanol- and HCl-induced gastric mucosal damage and gastric mucosal superoxide dismutase activity in rats.
Czeglédi B; Zsoldos T; Mózsik G
Acta Physiol Hung; 1984; 64(3-4):331-7. PubMed ID: 6598002
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.
Robert A; Nezamis JE; Lancaster C; Hanchar AJ
Gastroenterology; 1979 Sep; 77(3):433-43. PubMed ID: 456839
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotective action of roxatidine acetate HCl.
Shiratsuchi K; Fuse H; Hagiwara M; Mikami T; Miyasaka K; Sakuma H
Arch Int Pharmacodyn Ther; 1988; 294():295-304. PubMed ID: 2906796
[TBL] [Abstract][Full Text] [Related]
13. Gastroprotective effect of earthworm paste (Lampito mauritii, Kinberg) on experimental gastric ulcer in rats.
Prakash M; Gunasekaran G
Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):171-6. PubMed ID: 20391954
[TBL] [Abstract][Full Text] [Related]
14. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 in gastric mucosa and its role in the prevention of ulcers induced by acetyl salicylic acid in cats.
Konturek SJ; Radecki T; Brzozowski T; Piastucki I; Dembińska-Kieć A; Zmuda A; Gryglewski R
Digestion; 1981; 21(4):205-13. PubMed ID: 7215723
[TBL] [Abstract][Full Text] [Related]
16. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
17. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute surgical vagotomy on the mucosal content of 6-keto-PGF1 alpha, PGE2 and glutathione after intragastric 96% ethanol treatment in rats.
Sütö G; Király A; Vincze A; Mózsik G
Acta Physiol Hung; 1992; 80(1-4):205-11. PubMed ID: 1345188
[TBL] [Abstract][Full Text] [Related]
19. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
20. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
